Aihetaimujiang Anwaier

2PUBLICATIONS

16CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Sep 11, 2026

Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3-Rearranged Renal Cell Carcinoma: A Multicenter Real-World Study.

|Aug 07, 2026

APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

Pageof 1

Frequent Collaborators

2 joint publications

Xi Tian

2 joint publications

Jianfeng Yang

2 joint publications

Dingwei Ye

2 joint publications

Wenhao Xu

1 joint publications

Qintao Ge

1 joint publications

Shengdong Ge

1 joint publications

Zhongyuan Wang

1 joint publications

Jiahe Lu

1 joint publications

Yonghao Chen

1 joint publications

Hailiang Zhang

Frequent Collaborators

2 joint publications

Xi Tian

2 joint publications

Jianfeng Yang

2 joint publications

Dingwei Ye

2 joint publications

Wenhao Xu